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A B S T R A C T
Background: CT scan is a life-saving medical diagnostic tool, entailing higher levels of ionising radiation ex-
posure than conventional radiography, which may result in an increase in cancer risk, particularly in children.
Information about the use and potential health effects of CT scan imaging among young people in Spain is scarce.
Objective: This paper aims to estimate the number of radiation-related cancer cases which can be expected due to
the use of CT scanning in Spanish children and young adults in a single year (2013).
Methods: The 2013 distribution of number and types of CT scans performed in young people was obtained for
Catalonia and extrapolated to the whole Spain. Organ doses were estimated based on the technical character-
istics of 17,406 CT examinations extracted from radiology records. Age and sex-specific data on cancer incidence
and life tables were obtained for the Spanish population. Age and sex-specific risk models developed by the
Committee on Health Risks of Exposure to Low Levels of Ionizing Radiations (BEIR VII) and Berrington de
Gonzalez were used, together, with the dose estimates to derive the lifetime attributable risks of cancer in Spain
due to one year of CT scanning and project the number of future cancer cases to be expected.
Results: In 2013, 105,802 CT scans were estimated to have been performed in people younger than age 21. It was
estimated that a total of 168.6 cancer cases (95% CrI: 30.1–421.1) will arise over life due to the ionising ra-
diation exposure received during these CTs. Lifetime attributable risks per 100,000 exposed patients were
highest for breast and lung cancer. The largest proportion of CTs was to the head and neck and hence the highest
numbers of projected cancer cases were of thyroid and oral cavity/pharynx.
Conclusions: Despite the undeniable medical effectiveness of CT scans, this risk assessment suggests a small
excess in cancer cases which underlines the need for justification and optimisation in paediatric scanning. Given
the intrinsic uncertainties of these risk projection exercises, care should be taken when interpreting the predicted
risks.
1. Background
Nowadays, medical radiation has become the largest man-made
source of ionising radiation exposure for human beings (UNSCEAR,
2010), and in particular, computed tomography (CT) scanning largely
dominates the medical radiation exposures, accounting worldwide for
approximately 34% of the annual collective dose (UNSCEAR, 2010). CT
scanning is routinely used in patient management from diagnostic and
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treatment planning, to disease follow-up. As in most European coun-
tries, since its introduction in 1976, Spanish hospitals have progres-
sively adopted this diagnostic technique for its recognised clinical
value. Approximately 750 CT scanners are currently in use in Spain
(Ministerio de sanidad, servicios sociales e igualdad [Spanish Ministry
of Health, social services and equality], 2015), which annually per-
form>4.3 million CT scans (90.6% in the public healthcare system
(Ministerio de sanidad, servicios sociales e igualdad [Spanish Ministry
of health, social services and equality], n.d.)). According to interna-
tional data, CT imaging in children and adolescents is estimated to
account for 3–11% of the total CT activity (UNSCEAR, 2013). In this
age group, typical CT organ doses range between tens of mGy for an
organ in the scanning field to hundreds of μGy for a distal organ (Lee
et al., 2012; Santa-Olalla et al., 2005).
Epidemiological studies have shown that radiation exposure in
childhood is linked to a dose-related excess in the rates of tumours, in
particular brain tumours, leukaemia, breast and thyroid cancer
(Wakeford et al., 2010; Land, 1993; Ron et al., 1995; National Research
Council (U.S.), 2006; Monty, 2001; Neglia et al., 2006; Ron et al.,
1988), with higher lifetime risk of cancer per unit dose of radiation than
for exposure in adulthood (UNSCEAR, 2013). Because little direct evi-
dence is available on risks at doses below 100mGy, a linear no-
threshold (LNT) model is generally used to extrapolate the risk of
cancer for doses lower than this (National Research Council (U.S.),
2006) (as in the dose range for most CT imaging). Through this, several
studies have projected the risk of incident primary cancers associated
with diagnostic CT scan doses in young people (Miglioretti et al., 2013;
Journy et al., 2013; Egan et al., 2012; Journy et al., 2017; Li et al.,
2011; Su et al., 2014), adults (Richards et al., 2008; Smith-Bindman
et al., 2009) or in both (Sodickson et al., 2009; Gibson et al., 2014;
Berrington de González and Darby, 2004; Berrington de González,
2009) in different countries applying risk models derived by the BEIR
VII committee (National Research Council (U.S.), 2006) and other au-
thoritative agencies (US EPA, 2015; UNSCEAR, 2008; ICRP
(International Commission on Radiological Protection), 2007). These
studies estimated that a small, but non-negligible, excess in cancer risk
can be expected in relation to the widespread use of CT scanning.
In recent years, different studies in the UK (Pearce et al., 2012;
Berrington de Gonzalez et al., 2016), Australia (Mathews et al., 2013),
and Taiwan (Huang et al., 2014) have attempted to estimate directly
the magnitude of radiation-induced cancer risks from paediatric CT
scanning. The leukaemia and brain cancer risk estimates resulting from
the UK and Australian studies were larger than the estimates obtained
using the latest Life Span Study data (Hsu et al., 2013; Preston et al.,
2007). At present, methodological limitations such as the inclusion of
patients with cancer-prone syndromes, reverse causation, dosimetric
flaws, short follow-up and potential residual confounding due to un-
measured factors prevented deriving precise risk estimates from these
studies. Although the EPI-CT study, a large scale European study on CT
scan risks including over one million exposed children, will produce
results soon (Bosch de Basea et al., 2015), extrapolation from higher
dose studies remains the most solid basis for predicting risk from CT
scanning in young people.
For the first time, we estimated the use of CT imaging in Spanish
young population and subsequently assessed the potential impact of the
current practices of paediatric and young adult CT scanning on the
cancer burden of Spain.
2. Methods
2.1. Study population and related data
The Spanish National health care system reported that the annual
number of CT scans in Spain increased from 3,830,238 CT scans in 2010
to 4,307,391 in 2013 (Ministerio de Sanidad, Servicios Sociales e
Igualdad [Ministry of Health, Social Services and Equality], 2013),
according to the latest data at the time of this analysis. The distribution
of CT scans by age, sex and body part scanned was not available at the
country level. However, the Agency of Quality and Healthcare Eva-
luation of Catalonia (Agència de Qualitat i Avaluació Sanitàries de
Catalunya; AQuAS) of the Catalan Department of Health, made it ac-
cessible for the year 2015 for Catalonia, the 2nd most populated Au-
tonomous Community of Spain were 15.9% of its population reside. A
total of 374,270 CT scans were performed in the general population
aged 0 to 100 years. Approximately 3% of these were performed in the
population below 21 years of age. The Catalan relative distribution was
applied to the 2013 country-level figures in order to estimate the age,
sex and anatomical area-specific distribution of CT scans performed in
Spain, assuming stable (over the years) and similar CT distributions
between Catalonia and Spain.
In order to estimate the number of cancer cases that could be in-
duced by CT scan radiation, we used the most up-to-date age and sex-
specific Spanish cancer incidence rates available in the Cancer Incidence
in Five Continents (CIV) (Forman et al., 2007) series to infer the back-
ground rates of cancer among children and young adults. Due to the
lack of a national population-based registry, the incidence data are
based on the 2007 CIV rates provided by the 7 population-based
Spanish cancer registries. In the absence of more recent data we had to
assume the rates were similar to the 2013 rates and will continue to be
stable in the future (Forman et al., 2007). Spanish age and sex-specific
survival data (latest available data) was obtained for the year 2013 at
the National Statistics Institute (Instituto Nacional de Estadística)
(2013). Using data from the Spanish branch of the EPI-CT cohort study
we estimated that 6.64% CTs were performed in young people who
would not survive long enough (at least 5 years) to develop a poten-
tially radiation-induced cancer. These CTs were removed (by age bands,
sex and body area scanned) from the population at risk as was done in
Berrington's risk projections (2009). An important indication for CT
scanning is suspicion of and follow-up for cancer. These CT examina-
tions have to be excluded from our risk prediction analyses because
their related CT scan radiation would not be responsible for the onset of
the cancer they were used to diagnose/monitor. Therefore, we used the
data from the only Spanish EPI-CT participating hospital that provided
complete reason for the scan and estimated that, in 2013, out of the
2624 CT scans performed in patients aged 0 to 20 years, 8.8% were
related to a cancer code (suspicion, diagnosis or follow-up of the con-
dition). Therefore, this proportion of CT scans with similar age-sex-
anatomical area distribution was excluded.
2.2. Dosimetry at the organ level
For the estimation of absorbed doses to the organ, protocol para-
meters (kVp, mAs and pitch), machine specifications (model and
manufacturer), anonymous patient characteristics (age and sex), and
the descriptions of the anatomical areas scanned were extracted from
the DICOM headers of 33,947 CT performed on patients below 21 years
old between 2010 and 2013. This information was collected using the
software PerMoS (Luxembourg Institute of Science and Technology,
Luxembourg) in 9 EPI-CT participating Spanish hospitals. For each type
of CT examination, the start and end of the exposed body region were
defined on computational anthropometric phantoms by a radiologist
and validated by an independent paediatric radiologist. The gender-
specific phantoms used were compliant with the International
Commission on Radiological Protection references (ICRP 89) and re-
presented newborns, children at ages 1, 5, 10, and 15 and adults (ICRP,
2002). Due to the lack of registered information on the use of a bowtie
filter as the x-ray beam shaping attenuator, we used expert opinion to
impute the use of a head filter in newborns as by 50%:50% chance
irrespective of the scanned area. In older patients, head and body filters
were imputed in head/neck and thorax/abdomen+pelvis/extremities
scans, respectively. After discarding 16,541 examinations due to
missing parameters, absorbed organ-doses (mGy) were estimated for
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17,406 CTs using the NCICT version 1.0 software (Lee et al., 2015). The
minimum and maximum number of CT scans used to estimate doses for
a specific combination of age band and anatomical area scanned were 1
and 3876, respectively.
Finally, a look up table of median and interquartile range of organ
doses were compiled by 5-year age bands and examination type, and
assigned to each of the 2013 examinations.
2.3. Lifetime attributable risk models for several cancer sites
Given the site-specific irradiation and resulting heterogeneous
organ doses in each type of scan, we estimated the number of radiation-
induced cancer cases by applying the lifetime attributable risks (LAR);
the cumulative age-specific excess lifetime risks of cancer as a function
of organ-doses. The radiation-induced risk of cancer incidence was
calculated for the following 17 different cancer-sites: oral cavity and
pharynx, brain, colon, lung, urinary bladder, breast, stomach, thyroid,
liver, pancreas, kidney, prostate, esophagus, ovaries, rectum, uterus
and leukaemia by applying the risk models developed by the BEIR VII
committee (National Research Council (U.S.), 2006) and Berrington de
Gonzalez et al. (2009, 2012). They have been described elsewhere
(National Research Council (U.S.), 2006; Berrington de González, 2009;
Berrington de Gonzalez et al., 2012) and are explained in detail in the
supplementary web material. A dose and dose-rate effectiveness factor
(DDREF), modelled by a lognormal distribution with a geometric mean
of 1.5 and a geometric standard deviation equal to 1.35 was applied to
extrapolate the expected risk to the low and sparsely ionising radiation
doses delivered in a CT scan (National Research Council (U.S.), 2006),
reducing the ERR per unit dose accordingly. The risk models were es-
timated using risk-free latent periods of 5 years for solid cancers and of
2 years for leukaemia. The sex-averaged cumulative risks were calcu-
lated per 100,000 children and young adults undergoing 1 CT scan by
examination type (anatomical area) and patient characteristics (age).
The lifetime baseline risk (LBR) is the risk of developing cancer from
birth to the end of life, considered as 110 years of age, in the absence of
CT-scan radiation exposure. The LBR was estimated as well for 100,000
unexposed children and young adults. Then, the LAR by exposure age,
examination type and cancer-site was multiplied by the estimated
number of patients that received a CT scan in 2013, in order to estimate
the predicted number of cancer cases. We also calculated the attribu-
table fraction (AF) or proportion of cases which occur due to exposure






where CIe was the cumulative incidence among the exposed population
and CIu is the cumulative incidence in nonexposed only.
2.4. Uncertainties in cancer risk estimation
Several uncertainties that could have influenced the estimation of
the excess of radiation-induced cancer risk were considered statistically
independent and were taken into account in computing the combined
uncertainty. Treatment of uncertainty included the statistical un-
certainty in the estimates of risk parameters, in the DDREF value, in the
risk transport between populations and in the estimation of organ-
doses. Following the BEIR VII (National Research Council (U.S.), 2006)
and NCI methods (Berrington de González, 2009; Berrington de
Gonzalez et al., 2012), we drew lognormal probability distributions for
all the model parameters that provided confidence intervals in the
original BEIR VII cancer-sites and for the new NCI models (brain and
central nervous system) (Berrington de González, 2009; Berrington de
Gonzalez et al., 2012). Furthermore, normal and cumulative distribu-
tions were drawn respectively for two additional new NCI models:
prostate and uterus. The DDREF uncertainty was expressed as a prob-
ability distribution of possible values, following a lognormal
distribution with a geometric mean of 1.5 and geometric standard de-
viation equal to 1.35 guided by the methods developed by the BEIR VII
based on the LSS and experimental data (National Research Council
(U.S.), 2006). Uncertainty in dose estimates was included by drawing a
normal probability distribution for each CT scan type and age group
and sampling from them. Finally, the transport of risk estimates be-
tween populations was performed by assigning discrete weights equal
to 0.3 and 0.7 when appropriate to the EAR and ERR LAR (as the
Bernoulli probability that the relative and the additive risk transport,
independently, are correct) and calculating a weighted arithmetic mean
on a linear scale.
Uncertainties overall were combined and incorporated in the risk
estimates by applying Monte Carlo simulations to sample 10,000 times
from the probability distribution of each uncertain factor. The risk
analyses were performed with R version 3.1.1 and STATA 14.0
(StataCorp LP, Tx USA). Additionally to the mean LAR estimates, the
LAR obtained using the 2.5th and 97.5th percentile of the resulting
distribution (without previous assumptions on its possible symmetry)
were reported as credibility intervals (CrI).
3. Results
The extrapolation of the Catalan CT scan distribution to the entire
Spanish population resulted in an estimated 105,802 CT scans per-
formed in Spain in 2013 among those aged 20 years or less in a popu-
lation of 9.7 million people. Taking into account the 2013 0–20 years
old Spanish population, this represents a crude rate of 10.9 scans per
1000 Spanish children and young adults. Of this, 11,195 CT scans of the
spine, lumbar spine, sacrum, whole body, arms and ‘unknown anato-
mical area’ were not included in this risk projection exercise due to the
paucity of PACS-recorded CT technical parameters in these anatomical
locations to be used for dose estimation.
The estimated distribution of the remaining 94,607 CTs by age
group, sex and type of scan is displayed in Table 1. 52,283 scans
(55.3%) and 42,324 (44.7%) were undergone by male and female pa-
tients, respectively, with a male: female CT scan ratio of 1.45: 1 among
those below 10 years old, which decreased to 1.1: 1 among those in the
15–20 age group. Approximately 57% of all the 2013 CTs in young
people were performed in the 15–20 years age group. The proportion of
CT scans across age groups was generally similar for males and females,
though it was somewhat higher in females aged 15–20 years old
(59.97% of all CTs in females) than in males (54.68% CTs of all male CT
imaging). In both sexes, overall, the three more prevalent anatomical
areas scanned were: head (62.6%), abdomen (13.3%) and thorax
(10.32%).
The median organ doses for the brain, oral cavity and pharynx, lung,
stomach, pancreas and liver were consistently higher among the oldest
patients for those CT scan types that included these organs in the scan
field (Table 2). Brain-doses progressively increased with age, with head
examinations providing a range of median doses from 23.6 mGy in 0 to
4 years old children to 37.9 mGy among those that were 20 years of age.
The active bone marrow doses received during thoracic spine, ab-
domen, pelvis and chest-to-pelvis CT also increased with age, whereas
the bone marrow doses received during head and face CT examinations
showed the opposite pattern. Wide variability of organ-doses was
identified among those combinations of age, sex and scan type for
which fewer examinations were available for dose estimation, such as
chest-to-pelvis CT and thoracic spine CT (data not shown). With respect
to the organ doses received from different CT types, median brain doses
due to a face CT were half of those delivered in a head CT, in the dif-
ferent age groups. Similarly, the thyroid gland in the youngest age
group received 22.8mGy (average of median doses of males and fe-
males) during a cervical spine CT, slightly below 13mGy from a neck
and thoracic spine CT, and 8.1 mGy from a thorax CT. In the oldest age
group, a cervical spine CT delivered an averaged median thyroid dose
of 16.7 mGy, while neck, thoracic spine and thorax CT delivered 13.0,
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60.5 and 20.7 mGy to the thyroid, respectively.
In Table 3, the lifetime accumulated baseline (LBR) and the addi-
tional radiation-related probability of cancer incidence (LAR) are dis-
played for a number of cancer sites selected for being in or proximal to
the scanning field. For each cancer type, a single LBR value is provided
due to the cumulative nature of the risk from birth to the end of life
(considered as 110 years).
Lifetime attributable risks per 100,000 exposed patients were
highest for breast cancer in women who received one thorax, thoracic
spine or chest-to-pelvis CT, closely followed by lung cancer from one
thoracic spine or chest CT and thyroid cancer from one chest or cervical
spine CT scan. Considering all cancer sites together, the examinations
that conferred the highest LAR were: chest-to-pelvis, thorax, thoracic
spine and abdomen CT with total LAR values such as 23,674.2,
20,995.8, 18,654.8, and 17,047.2 per 100,000 exposed, respectively.
The examination type that conferred the lowest LAR was neck CT, with
a total LAR of 3998.8 per 100,000 exposed.
The lifetime attributable risks did not show a consistent dependence
on age at exposure, with risk patterns in different directions among
those exposed at older ages (15–20 year olds) compared with lower
ages (< 1 year) depending on the area scanned. The risks for brain
cancer consistently decreased with increasing age at the time of the
exposure for virtually all CT scan types whereas leukaemia risks pre-
sented a decreasing pattern with increasing age for head, face, neck and
thorax CT and an unclear pattern for the remaining CT scan types.
Among the oldest age group (15–20 year olds) the highest predicted
risks (LAR×105) were observed for breast cancer among women fol-
lowing a thoracic spine CT (LAR=209.3). In the youngest group
(< 1 year olds) the highest risks per 100,000 exposed individuals were
observed for breast cancer following a CT scan of the thorax
(LAR=458.8). LAR showed a wide variability according to the scan
type.
Applying the LAR (95% CrI) to the estimated age-sex and body part
scanned distribution of the CT examinations in 2013 among those aged
0 to 20 in Spain, we predicted that 168.6 (30.1–421.1) additional
cancer cases may occur over the life course of this population due to the
doses received during CT scanning (Table 4). This is in comparison to
the approximately 39,028 cancers expected over life due to other
causes, hence an attributable risk percent (AR%) of about 0.43%
(0.08%–1.1%).
The CT scans that contributed most to the projected cancer cases are
shown in Table 4. The predicted incident cancer cases were, in order of
frequency, cancers of the thyroid (31.8 (2.8–101.8) cases; 18.9% of all
excess cases), oral cavity and pharynx cancer (22.7 (4.7–48.8) cases;
13.5% of all excess cases), lung cancer (18.4 (3.0–48.6) cases; 10.9% of
all excess cases), colon cancer (17.7 (3.8–38.9) cases; 10.5%) closely
followed by breast cancer (14.8 (2.3–41.3) cases; 8.8%). The majority
of the projected cancer cases were found among those in the highest age
group at the time of the exposure, accounting for 43.8% of all the in-
cident cases (n= 74 (17.2–151.4)). Overall, 38.6% (n= 65.1
(9.5–171.4)) and 25.8% (n= 43.5 (9.3–95.5)) of all the predicted
cancer cases are estimated to result from head and abdomen CT ima-
ging, respectively. Although the total LAR of a single head CT (summing
all the cancer site specific LAR) was inferior to that of an abdomen
examination (6317.8 vs. 17,047.3 per× 105 exposed), the elevated
head scan frequency (62.6% of all procedures) translated into a higher
number of predicted cancer cases (n=65.1 (9.5–171.4)), in particular,
91.5% of all the brain cancer cases and 88.5% of the oral cavity and
pharynx cancers. Thorax, chest-to-pelvis and leg CTs accounted for
most of the remaining expected cancer cases (24.3 (5.5–118.2), 3
(1.3–10.2) and 2.6 (1.6–7.6), respectively) while the rest of the CT
scans contributed minimally to the predicted future cancer cases. Head
CTs were the main contributor (70.1%) to the leukaemia cases too
(n= 6 (1.6–21.0) due to the extremely high frequency of this ex-
amination.
4. Discussion
According to our estimations, 105,000 CT scans were performed in
2013 in the young population in Spain, dominated by far by head CTs,
followed by abdomen CTs as a result of a distribution largely driven by
the 15–20 age group. The unprecedented use of the examination set-
tings of approximately 17,400 real CT scans warranted the estimation
of robust and realistic organ-doses currently used in clinical practice.
Table 1
Estimated distribution of CT scans by sex and age groups in Spain, in 2013.
CT scan type <1 1–4 5–9 10–14 15–20 Total
N % N % N % N % N % N %
Male
Head 2191 (66.3%) 3820 (75.3%) 4256 (66.9%) 6012 (67.1%) 16,938 (59.3%) 33,217 (63.5%)
Abdomen 377 (11.4%) 101 (2.0%) 373 (5.9%) 746 (8.3%) 4954 (17.3%) 6551 (12.5%)
Thorax 566 (17.1%) 755 (14.9%) 1051 (16.5%) 1051 (11.7%) 2060 (7.2%) 5483 (10.5%)
Leg 12 (0.4%) 15 (0.3%) 128 (2.0%) 412 (4.6%) 1520 (5.3%) 2087 (4.0%)
Face 12 (0.4%) 37 (0.7%) 175 (2.8%) 223 (2.5%) 927 (3.2%) 1374 (2.6%)
Cervical spine 35 (1.1%) 110 (2.2%) 110 (1.7%) 204 (2.3%) 726 (2.5%) 1185 (2.3%)
Neck 21 (0.6%) 195 (3.8%) 176 (2.8%) 100 (1.1%) 652 (2.3%) 1144 (2.2%)
Trunka 23 (0.7%) 13 (0.3%) 21 (0.3%) 83 (0.9%) 404 (1.4%) 544 (1.0%)
Pelvis 58 (1.8%) 13 (0.3%) 40 (0.6%) 90 (1.0%) 185 (0.6%) 386 (0.7%)
Thoracic spine 12 (0.4%) 15 (0.3%) 27 (0.4%) 38 (0.4%) 220 (0.8%) 312 (0.6%)
Total 52,283 (100%)
Female
Head 1494 (66.2%) 2564 (71.0%) 2802 (65.2%) 3683 (54.4%) 15,479 (61.0%) 26,022 (61.5%)
Abdomen 253 (11.2%) 96 (2.7%) 233 (5.4%) 816 (12.0%) 4629 (18.2%) 6027 (14.2%)
Thorax 346 (15.3%) 746 (20.7%) 709 (16.5%) 848 (12.5%) 1636 (6.4%) 4285 (10.1%)
Leg 12 (0.5%) 4 (0.1%) 117 (2.7%) 692 (10.2%) 1233 (4.9%) 2058 (4.9%)
Face 1 (0.0%) 4 (0.1%) 131 (3.0%) 276 (4.1%) 654 (2.6%) 1066 (2.5%)
Neck 35 (1.6%) 71 (2.0%) 116 (2.7%) 231 (3.4%) 437 (1.7%) 890 (2.1%)
Cervical spine 12 (0.5%) 70 (1.9%) 84 (2.0%) 99 (1.5%) 487 (1.9%) 752 (1.8%)
Trunka 35 (1.6%) 15 (0.4%) 5 (0.1%) 38 (0.6%) 406 (1.6%) 499 (1.2%)
Pelvis 58 (2.6%) 26 (0.7%) 61 (1.4%) 44 (0.6%) 243 (1.0%) 432 (1.0%)
Thoracic spine 12 (0.5%) 15 (0.4%) 38 (0.9%) 49 (0.7%) 179 (0.7%) 293 (0.7%)
Total 42,324 (100%)
a Combined CT scan of chest, abdomen and pelvis.
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This is an alternative approach to other dosimetric strategies observed
in similar studies based on surveys (Berrington de González, 2009),
scanner protocols (Journy et al., 2013; Egan et al., 2012), on both
(Journy et al., 2017) or derived from smaller samples of clinical data
(Miglioretti et al., 2013). Our estimated doses were similar to pre-
viously published for CT imaging, showing the robustness of the dif-
ferent dosimetric approaches (Miglioretti et al., 2013; Journy et al.,
2013; Su et al., 2014; Pearce et al., 2012). For example, our estimation
of brain doses in a head CT for the 0 to 4 years age group was 23.6 mGy,
and 28.8mGy in Miglioretti et al. (2013) and 28.0 in Pearce et al.
(2012) in the 1–4 year olds. We also estimated red bone marrow doses
of 2.2 mGy for a thorax CT in 5 to 9 years of age, whereas Journy et al.
(2013), Miglioretti et al. (2013)) and Pearce et al. (2012) reported red
bone marrow doses of 1, 3.9 and 3.0mGy for the same procedure and
age group, respectively. Thyroid doses for a thorax CT were similar to
those estimated by Journy et al. (2013) and slightly larger than those by
Table 2
Median, 25th and 75th percentile organ-doses (mGy) across age groups for the relevant organs included in the scanned area by type of CT scan.
CT type/organ dose < 1 year 1–4 years 5–9 years 10–14 years 15–20 years
Med 25thp 75thp Med 25thp 75thp Med 25thp 75thp Med 25thp 75thp Med 25thp 75thp
Head CT
Brain 23.6 13.2 32.7 27.0 17.2 33.1 27.9 17.8 38.4 33.4 23.3 43.5 37.9 17.3 43.1
Oral cavity 6.4 1.9 22.5 26.7 13.5 33.2 25.8 16.4 34.7 26.8 16.7 33.3 26.8 15.4 31.9
Active bone marrow 8.2 4.4 11.8 6.9 3.5 9.3 4.6 2.6 6.2 3.1 1.9 4.1 2.3 1.3 2.7
Face CT
Brain 12.5 7.6 20.0 15.5 8.2 24.0 18.0 9.5 23.0 17.0 9.2 17.5 15.3 5.9 17.1
Oral cavity 28.7 17.3 41.6 26.4 14.7 39.0 36.3 19.0 37.6 29.3 16.7 34.2 26.3 11.4 32.7
Active bone marrow 6.0 3.9 8.7 3.7 2.1 5.5 3.4 1.7 4.0 2.2 1.3 2.6 1.4 0.5 1.7
Cervical spine CT
Thyroid 22.8 13.5 43.8 31.8 20.2 51.6 37.6 23.1 49.1 35.2 15.1 48.8 16.6 15.8 18.3
Active bone marrow 2.6 1.7 5.1 2.2 1.3 3.7 2.6 1.6 3.0 2.4 1.6 3.0 2.2 2.0 2.4
Neck CT
Thyroid 12.8 5.0 17.3 22.5 10.2 33.1 23.5 16.8 29.4 15.8 8.0 31.6 13.0 7.6 33.0
Active bone marrow 1.8 1.5 2.5 2.0 1.0 2.4 1.5 1.2 1.9 1.4 0.6 2.3 1.5 0.7 2.7
Esophagus 4.6 2.0 5.7 4.9 2.1 7.2 4.7 3.3 5.8 4.7 1.9 8.3 5.3 2.8 9.5
Thoracic spine CT
Thyroid 12.8 10.4 15.9 22.6 17.7 27.6 24.8 11.8 33.0 21.6 13.3 25.9 60.5 60.5 60.5
Active b. marrow 4.5 4.0 5.8 4.5 3.8 5.7 6.3 5.0 7.3 6.3 4.5 10.7 12.1 12.1 12.1
Breasta 11.8 11.2 18.5 16.6 12.6 19.8 19.1 14.9 22.9 20.8 15.0 31.6 38.7 38.7 38.7
Lungs 14.5 14.2 22.2 20.2 15.4 23.7 22.5 17.5 27.5 23.4 16.9 38.3 42.1 42.1 42.1
Esophagus 12.8 11.5 17.3 16.6 12.7 19.5 19.1 15.6 22.8 19.1 13.8 29.9 35.0 35.0 35.0
Thorax CT
Thyroid 8.1 4.7 11.8 10.8 8.0 18.6 13.4 8.7 24.3 23.9 7.7 37.5 20.7 4.9 34.7
Active bone marrow 2.7 2.0 4.3 2.2 1.6 3.9 3.3 1.8 5.8 5.8 1.7 9.0 5.0 1.0 9.9
Breasta 2.7 2.0 4.3 2.2 1.6 3.9 3.3 1.8 5.8 5.8 1.7 9.0 5.0 1.0 9.9
Lungs 8.5 6.2 14.2 9.2 6.9 15.7 11.4 6.3 20.3 18.8 5.8 28.8 15.5 3.2 30.3
Esophagus 7.2 5.4 11.4 7.7 5.9 13.4 10.1 5.5 18.2 16.6 4.9 25.0 13.9 2.9 24.8
Abdomen CT
Stomach 6.6 5.5 11.7 13.2 7.0 25.8 19.7 13.8 28.1 25.3 17.3 32.9 22.3 11.7 27.4
Colon 7.1 6.0 14.1 14.5 8.3 29.4 22.8 16.8 32.7 30.4 20.4 39.0 27.2 14.0 33.5
Rectum 5.6 3.9 9.3 9.4 5.4 17.8 12.4 8.0 18.0 16.8 11.0 23.6 19.5 9.9 24.0
Pancreas 6.7 5.8 12.9 12.9 7.3 26.4 19.1 13.6 27.7 25.8 17.5 33.1 24.4 11.2 29.7
Liver 6.5 5.2 11.2 12.2 6.7 24.1 17.9 12.3 25.4 22.7 15.4 30.1 19.2 10.9 23.7
Kidney 6.9 5.8 12.9 13.6 7.4 26.9 20.0 14.4 29.2 27.3 18.6 34.5 25.1 12.7 30.9
Trunk CT
Thyroid 5.6 2.4 7.9 7.6 4.2 11.7 10.1 4.7 19.7 24.9 8.4 47.1 12.6 8.6 38.9
Active bone marrow 3.1 2.6 5.6 5.8 3.2 9.6 11.0 8.9 19.0 15.4 8.1 23.6 8.3 5.7 25.5
Breasta 5.8 5.0 9.8 10.1 6.5 17.0 18.8 12.8 27.4 21.2 11.2 33.6 11.9 8.1 36.7
Stomach 7.2 6.1 11.8 13.0 8.4 22.0 24.6 17.5 35.7 25.6 13.7 40.6 13.7 9.4 42.3
Colon 7.6 6.3 11.9 14.4 9.3 24.1 27.2 19.4 39.1 27.5 14.8 43.6 13.4 9.1 41.1
Rectum 6.2 4.4 9.0 11.3 7.4 19.8 17.0 14.7 29.3 21.3 11.9 33.7 10.7 7.3 32.9
Pancreas 7.1 6.1 11.7 12.7 8.3 21.5 22.8 16.5 33.0 23.2 12.5 36.8 13.2 9.0 40.5
Liver 7.1 6.1 11.7 12.5 8.1 21.2 23.5 16.6 34.1 24.7 13.2 39.2 13.8 9.4 42.6
Kidney 7.2 6.2 11.8 13.0 8.5 22.0 23.8 17.4 34.2 25.4 13.4 40.1 13.3 9.1 40.9
Pelvis CT
Urinary bladder 15.2 8.1 28.1 25.3 11.0 34.2 24.1 13.0 37.7 32.9 20.0 41.8 39.8 3.7 40.8
Prostateb 10.7 3.1 23.3 11.5 5.2 27.1 9.9 5.8 27.2 21.0 9.6 32.7 28.3 2.8 30.9
Ovariesa 14.6 4.7 27.1 24.2 16.6 34.1 24.1 13.5 32.2 24.7 18.5 30.3 24.7 18.5 30.3
Uterusa 13.7 4.3 26.6 23.1 16.0 32.8 23.1 12.6 30.7 22.7 17.3 28.4 22.7 17.3 28.4
Leg CT
Active bone marrow 8.4 8.4 8.4 5.8 5.3 7.5 8.1 7.5 8.8 3.0 1.4 3.1 2.1 1.1 3.0
Prostateb 12.8 12.8 15.8 12.8 12.8 15.8 47.5 47.0 47.5 21.6 20.8 27.1 21.5 21.5 21.5
Ovariesa 10.4 10.4 10.4 8.9 7.5 11.7 8.9 8.9 16.1 6.9 4.7 8.4 5.0 3.4 5.4
Uterusa 11.0 11.0 11.0 10.2 8.6 13.8 10.2 10.2 18.8 8.8 4.5 10.3 4.5 3.1 4.9
a Only in females.
b Only in males.
M. Bosch de Basea et al. Environment International 120 (2018) 1–10
5
Su et al. (2014). Our reconstruction of doses for a given examination
type is based on an assessment of the typically exposed organs and
tissues provided by expert judgment, and does not allow variability
among patients. Therefore, the absorbed doses of those organs partially
included or in the periphery of the scan volumes may be overestimated,
as could be the case of the thyroid in thorax CTs or underestimated, if
the landmarks over the computational phantom excluded a truly irra-
diated organ. Consequently, they have to be taken with caution, as it is
suggested that the comparison of the estimated doses among studies is
made only for the organs entirely included in the scanning field (Hall
and Giaccia, 2006). Although historical data suggests that greater at-
tenuation of the incident radiation (and therefore lower organ-doses)
Table 3
Estimated sex-averaged lifetime background risks (LBR) and lifetime attributable risks per 100,000 exposed subjects (LAR) of the tissues and organs exposed by CT
scan type by age group of exposure.
CT type/cancer site LBR×10−5a LAR×10−5 from age (in groups) at the time of the CT scan to age 110
<1 year 1–4 years 5–9 years 10–14 years 15–20 year
Head CT
Brain 790.7 34.22 28.30 22.22 18.78 16.65
Oral cavity and pharynx 1435.7 25.73 23.44 34.02 47.94 35.37
Leukaemia 1281.4 43.27 33.61 15.10 6.32 2.80
Face CT
Brain 790.7 13.75 11.35 11.62 9.85 6.57
Oral cavity and pharynx 1435.7 71.72 65.58 52.80 29.83 39.28
Leukaemia 1281.4 22.73 17.73 5.14 5.15 1.95
Cervical spine CT
Thyroid 532.7 131.02 107.06 170.71 82.95 74.38
Leukaemia 1281.4 16.41 12.65 3.27 1.27 3.40
Neck CT
Thyroid 532.7 57.35 46.90 33.38 25.32 46.07
Leukaemia 1281.4 7.32 5.64 3.11 3.16 2.30
Esophagus 477.7 4.06 3.75 3.38 2.32 3.06
Thoracic spine CT
Thyroid 532.7 101.93 83.30 117.94 69.75 26.27
Leukaemia 1281.4 9.70 7.66 6.14 7.70 8.64
Breastc 9416.5 318.60 282.27 280.99 207.00 209.25
Lungs 5226.8 129.71 118.05 185.77 153.72 113.93
Esophagus 477.7 11.59 10.67 13.42 9.24 8.35
Thorax CT
Thyroid 532.7 252.14 206.01 41.10 70.26 25.40
Leukaemia 1281.4 40.20 31.10 7.47 6.36 5.22
Breastc 9416.5 458.75 406.49 250.29 163.54 159.07
Lungs 5226.8 238.07 216.58 111.39 97.70 96.84
Esophagus 477.7 23.17 21.34 10.07 10.52 7.15
Abdomen CT
Stomach 1888.0 62.80 57.19 53.20 56.50 54.66
Colon 5571.0 83.61 77.31 93.27 81.35 121.12
Rectosigmoid 2404.5 6.24 5.75 12.41 9.17 8.26
Gallbladder – – – – – –
Pancreas 1379.5 14.68 13.61 18.44 14.44 18.09
Liver 1105.4 30.87 28.23 27.81 26.29 19.60
Kidney 1087.4 13.61 12.28 15.96 15.61 14.43
Trunk CT
Thyroid 532.7 18.36 15.05 34.35 37.47 51.95
Leukaemia 1281.4 13.69 10.76 6.67 14.13 7.46
Breastc 9416.5 158.67 140.59 219.59 204.83 180.79
Stomach 1888.0 36.05 32.82 55.37 55.55 45.29
Colon 5571.0 69.53 64.36 100.66 111.06 74.23
Rectosigmoid 2404.5 7.45 6.87 9.22 11.49 7.67
Pancreas 1379.5 9.48 8.79 16.45 20.59 13.89
Liver 1105.4 16.67 15.20 32.26 32.67 21.72
Kidney 1087.4 10.68 9.65 15.36 14.61 11.79
Pelvis CT
Urinary bladder 4561.3 105.36 97.53 91.61 106.17 96.81
Prostateb 13,534.7 39.68 36.88 41.44 33.64 38.02
Ovariesc 1290.7 10.05 9.23 23.23 33.94 13.94
Uterusc 239.5 21.71 19.87 25.69 20.97 12.89
Leg CT
Leukaemia 1281.4 28.21 21.82 4.99 15.27 2.47
Prostateb 13,534.7 41.70 38.76 42.64 81.90 38.35
Ovariesc 1290.7 16.12 14.93 9.17 8.05 4.55
Uterusc 239.5 11.07 10.11 9.07 10.55 4.00
a Calculated from birth to age 110.
b Only in male patients.
c Only in female patients.
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would be expected in the oldest patients, the pattern of age-specific
doses in this study is different, with higher median doses on average, for
the same procedures, among older patients. This likely reflects the fact
that, by 2013, most of the hospitals used paediatric specific protocols
adapted (1) to patient height and weight, (2) to clinical indication and
(3) optimised to minimise doses in younger patients, compared to the
use of adult protocols in the oldest patients.
The fact that LAR for site-specific cancers showed no clear depen-
dence on age at exposure may seem paradoxical when data from the
LSS and other studies show clearly an age at exposure dependence of
risk. In particular, it is observed that exposure in childhood tends to
result in higher risks than exposure later in life, particularly for leu-
kaemia, thyroid cancer and breast cancer (UNSCEAR, 2013). The ab-
sence of clear pattern here is, in fact, related to the higher median doses
received in general by the older patients, offsetting the higher risk
coefficients in younger patients. The predicted gender-averaged LBR of
brain cancer and leukaemia were slightly higher for the Spanish com-
pared to the French population (Journy et al., 2013), whereas the op-
posite was observed for thyroid and breast cancer, although in general
terms the LBR for the cancer sites assessed in both studies were similar
in order of magnitude, reflecting similar cancer incidence and survival
rates.
In our study, the highest LAR following CT scan radiation exposure
were found for breast, lung, and thyroid cancer. For the three
neoplasms, radiation exposure during childhood is a well-documented
risk factor (UNSCEAR, 2013; National Research Council (U.S.), 2006;
Hall and Giaccia, 2006; Howe and McLaughlin, 1996; Ronckers et al.,
2005; Ozasa et al., 2012; Nikiforov and Gnepp, 1994). In the French
study, higher breast cancer risks were reported (Journy et al., 2013)
whereas similar lifetime risks of brain cancer after a head CT (per
100,000 exposed) were presented for the those groups of children aged
5 years and older (Journy et al., 2013). Chest-to-pelvis CTs conferred
the highest lifetime risks when taking into account all the cancer sites
(LAR per 100,000 exposed patients). This was related to a combination
of high specific organ-doses and higher radiosensitivity of the breast
and colon. We estimated that the organ-doses received by the young
population who underwent a CT scan during 2013 would produce ap-
proximately 168.6 additional cancers over life (mainly thyroid, oral
cavity and pharynx, lung and colon cancer). This estimation might be
conservative given the fact that over 11,000 CT scans (10%) were
discarded due to unavailable parameters for dose estimation. Further-
more, the present estimation might underestimate the actual number of
cancer cases if within the discarded scans conducted due to cancer
suspicion there is an elevated fraction of cancer-free results.
In a wider age range population (0 to>85 years), Berrington de
González (2009) projected primarily lung and colon cancer cases re-
sulting from one year of CT imaging (Berrington de González, 2009).
Similar attributable fractions of radiogenic cancer cases were observed
Table 4
Predicted cancer cases by cancer site and age group.
Cancer site/CT type Total expected cancers from all 2013 CT scans (95% CrI) Expected number of cancers by age group and selected CT scans
< 1 year 1–4 years 5–9 years 10–14 years 15–20 years
Thyroid cancer 31.8 (2.8–101.8)
Head CT 7.99 11.36 0.55 0.55 1.74
Thorax CT 1.60 2.53 0.59 1.11 0.81
Oral cavity cancer 22.7 (4.7–48.8)
Head CT 0.88 1.40 2.47 4.29 11.06
Face CT 0.01 0.03 0.16 0.14 0.63
Lung cancer 18.4 (3.0–48.6)
Thorax CT 1.69 2.73 1.70 1.61 3.27
Abdomen CT 0.30 0.09 0.12 0.51 1.67
Colon cancer 17.7 (3.8–38.9)
Abdomen CT 0.49 0.13 0.57 1.18 11.12
Thorax CT 0.39 0.56 0.36 0.54 0.71
Chest-to-pelvis 0.03 0.02 0.03 0.13 0.55
Breast cancera 14.8 (2.3–41.3)
Thorax CT 1.35 2.56 1.57 1.25 2.46
Abdomen CT 0.43 0.14 0.22 0.78 1.77
Brain cancer 12.4 (2.7–25.8)
Head CT 1.31 1.88 1.66 1.96 5.32
Stomach cancer 11.8 (2.4–27.2)
Abdomen CT 0.34 0.10 0.28 0.85 5.02
Thorax CT 0.55 0.83 0.62 0.79 1.45
Bladder cancer 10.6 (2.5–22.9)
Abdomen CT 0.30 0.08 0.60 0.53 4.64
Leg CT 0.03 0.02 0.21 1.04 1.15
Leukaemia 8.9 (1.6–21.0)
Head CT 1.55 2.09 1.10 0.60 0.85
Thorax CT 0.33 0.39 0.11 0.11 0.18
Abdomen CT 0.13 0.03 0.02 0.11 0.54
Remaining sites
Liver cancer 5.2 (1.0–12.4) 0.50 0.52 0.57 0.82 2.80
Pancreas cancer 3.4 (0.7–7.9) 0.23 0.24 0.33 0.42 2.18
Kidney cancer 2.8 (0.6–6.6) 0.22 0.21 0.27 0.41 1.73
Esophagus cancer 2.1 (0.3–5.6) 0.32 0.45 0.28 0.33 0.70
Prostate cancerb 2.0 (0.6–4.1) 0.14 0.08 0.13 0.44 1.17
Rectum cancer 1.5 (0.3–3.2) 0.08 0.04 0.12 0.24 1.02
Ovaries cancera 1.5 (0.4–2.9) 0.05 0.04 0.08 0.32 0.97
Uterus cancera 1.0 (0.3–2.0) 0.05 0.03 0.06 0.18 0.70
Total by age groups 168.6 (30.1–421.1) 23.14 31.10 16.70 23.83 73.84
% 13.7% 18.4% 9.9% 14.1% 43.8%
a Only in female patients.
b Only in male patients.
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in comparable studies (Web Table 1).
It is important to bear in mind that our organ-dose estimates might
be affected by some degree of uncertainty, given the fact that we did
not take into account the patient body shape and orientation due to
unavailability of height, weight and patient position information. Also,
the definition of the prototypical scan landmarks by a paediatric radi-
ologist might not describe the potential variability in clinical practice
when scanning a patient. We estimated that a variation of± 10% on
the landmarks of the head and abdomen CT would result in a variation
of 0.1–0.8% on the brain and of 0.5–31.5% colon doses, respectively
when keeping the rest of parameters the same. Additionally, although
the use of the bowtie filter in newborns was imputed based on expert
opinion and common paediatric CT protocols we would not expect that
this would introduce a substantial error in the dose estimations given
the fact that newborn CT scans represented 8.4% of all the CTs used for
dose estimation. Despite of this, we acknowledge the contributing effect
of these factors to the existing difficulty and variability in organ-dose
estimation. Furthermore, despite of the substantial number of CT scan
parameters for dose estimation, these may differ from those used in
other Spanish hospitals in terms of total number of detectors, number of
slices per scan or slice width. Additionally, tissues such as the bone
marrow will present substantial absorbed dose heterogeneity due to
their own physical distribution throughout the body and partial irra-
diation of the CTs.
The risk models used in this paper, which are mainly based on
cancer incidence within the LSS cohort, implicitly carry some un-
certainties given the fact that 1) the BEIR VII report used constant va-
lues as risk-free latent periods between exposure and onset of disease
despite the lack of precise knowledge on the aetiology of cancer among
young people (National Research Council (U.S.), 2006) 2) the DDREF
distribution centered around 1.5 was based on experimental data and
the latest LSS data, and reflects the inherent uncertainty in this para-
meter 3) the DDREF may not perfectly fit all cancer sites, 4) the
transport of risk estimates between the Japanese and any population
implied combining the EAR and ERR LAR in an imperfect way that
approximates their relationship with baseline cancer rates (National
Research Council (U.S.), 2006) and 5) the BEIR VII assumed an un-
derlying linear no threshold dose-response (LNT) model modified by
the age of exposure, attained age and gender although the mechanisms
of radiogenic cancer at low doses are not fully understood.
The use of alternative minimal latent periods was assessed by the
BEIR VII committee resulting in no different risk estimates, thus, con-
firming the adequacy of using 5 years for solid cancer and 2 years for
leukaemia in the risk calculations. Based on observations in various
epidemiologic data sets, alternative DDREF values (2, 2 and ≤3) were
proposed by the US EPA (2015), International Commission on
Radiological Protection (ICRP) 103 report (2007) and the United
Nations Scientific Committee on the Effects of Atomic Radiation
(UNSCEAR 2006) (2008), respectively, resulting in substantially dif-
ferent risk estimates. In particular, it was described that moving from a
risk reduction factor of 2 to 1.5 increased solid cancer risk estimates by
33% (Cucinotta and Kim, 2012). The different BEIR VII committee,
UNSCEAR, ICRP and EPA use of ERR and EAR mixtures for risk trans-
port between populations suggest a lack of consensus about the ap-
propriateness of one combination over the other. In general though, the
BEIR VII committee considered that given the wide confidence intervals
that the ERR and EAR presented for the risk estimates in most popu-
lations both models fitted reasonably well the data (National Research
Council (U.S.), 2006). Also, the UNSCEAR 2006 report (2008) used
both the additive and multiplicative models to estimate risks with no
inclination for one over the other, as did the ICRP 103 (2007), ar-
ithmetically averaging both values. The US EPA (2015) used similar
weights for the ERR and EAR models than the ones used here but
combined the models using a weighted arithmetic mean in a linear scale
instead of a geometric mean in a log scale, resulting in LAR projections
6 to 12% higher than the ones derived by the BEIR VII (US EPA, 2015).
Finally, the adopted LNT model controversy is still unsettled, especially
in the low-dose range, where the expected small radiogenic health ef-
fects are difficult to detect against the normal fluctuations in the
baseline cancer incidence rates. Despite this, the increasingly large
body of epidemiological and experimental evidence currently supports
the use of this model and justifies that the US EPA (2015), UNSCEAR
2006 (2008) and ICRP 103 (2007) report have adopted it as well. Re-
garding the risk models used, the ERR and EAR models proposed by the
ICRP 103 (2007) present a slightly smoother decrease in risk with age-
at-exposure per decade than the ones used here and the decrease con-
tinues even beyond age 30. This would result in proportionally larger
number of projected cancer cases. On the other hand, the UNSCEAR
2006 ERR and EAR models are cancer specific and in most cases they
only allow to be modified by attained age (UNSCEAR, 2008). The BEIR
VII (National Research Council (U.S.), 2006) approach did not account
for the uncertainties associated to the definition of the relative biolo-
gical effectiveness (RBE) per unit absorbed doses used to evaluate the
radiogenic cancer risks on the LSS cohort. According to this, the esti-
mation of risks from low-dose x-ray exposure may be underestimated by
a factor of 2 or 3 (National Research Council (U.S.), 2006). Ad-
ditionally, the BEIR VII analyses failed to address other sources of un-
certainty such as the fact that the LSS population exposed at younger
ages is still at risk of developing radiation-induced malignancies, as-
suming that the observed risk patterns were stable for the youngest
survivors (National Research Council (U.S.), 2006). Also, the BEIR VII
report assumed that although the LSS cohort registered solid cancer
incidence after 1958 most probably missing some early childhood
cancers, the risks might be similar to those observed in the initial years
of follow-up. An increased number of cancer cases within the LSS co-
hort would translate in different risk coefficients and values for the
parameters that express the relationship of risk with attained age and
age at exposure. All in all, it is important to regard the obtained cancer
estimates as the result of statistical and subjective uncertainties, de-
rived from the BEIR VII committee and NIH adoption of risk models,
parameters, risk-reduction factors, model mixtures and latency periods
based on specific datasets and underlying assumptions. The effect of
these unaccounted sources of uncertainty may result in an influential
contribution to the overall uncertainty of the present risk estimates.
One limitation of our study is that we extrapolated data from
Catalonia to the rest of the country. To our knowledge there is no a
priori reason to expect different CT scanning practices between
Catalonia and Spain. This does, however, introduce further uncertainty
in our cancer estimates. Additionally, cancer incidence was assumed
stable from 2007 to 2013, although some variability was observed in
the previous years. Due to the annual fluctuation of rates of rare cancer
types, we did not extrapolate the site-specific cancer incidence of 2007
onwards. Therefore, if 2013 cancer incidence differed from 2007, a
slightly different LAR would be expected given that the ERR model
contributes substantially in the risks for most cancer sites. However, no
major changes would be expected for breast cancer due to the fact that
it relies entirely on the EAR model. The assumption of stability over
time of the life table data is another source of uncertainty. Finally, we
estimated the independent risks attributable to one CT scan, which is
aligned with the fact that most population in this age-range will receive
a single CT, as observed in a previous study (Bosch de Basea et al.,
2016). Although the previously mentioned factors enlarge the margins
of uncertainty of this assessment exercise, the statistical, dosimetric and
modelling methodology used is consistent with the published literature
(National Research Council (U.S.), 2006). Despite the medical effec-
tiveness of CT scan, the results of this risk analyses provide some in-
formation regarding the small but undeniable CT-related excess in
cancer, the second leading cause of disease-related death in the Spanish
population (Instituto Nacional de Estadística. (National Statistics
Institute), 2014). While the relative excess risk of cancer over life is
estimated to be small (0.43%) compared to the baseline cancer risk in
the population, it should be noted that our estimates are based only on
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one year of scanning. It is not uncommon for patients to receive more
scans in childhood and adolescence, as well as over life, with some
patients receiving tens of scans in a few years for the follow-up of some
conditions. Consequently, cancer risks in those patients will be greater
and care must be taken to ensure they receive appropriate radiological
protection.
Risk estimates in this study were based on recent CT scanning
practices in Spanish young people. Studies indicate that, within the
radiological and radiation protection communities, the increased con-
sciousness of the potential health consequences of CT scanning have
impacted both the scanning frequency in young people and the radia-
tion dose levels used (Singh et al., 2009). Hence, a similar exercise
conducted on CT scanning in earlier years would most likely have re-
sulted in a higher lifetime excess of cancer. In the absence of accurate
direct estimates of risks from CT exposed patients followed up for long
time periods, risk projection studies provide important information to:
a) enforce the CT indication guidelines to minimise CT scans without a
clear medical benefit, b) promote dose-reduction practices and the
optimization of CT acquisition parameters within staff radiologists and
technologists, and c) favour the steady renewal of scanners in Spain by
those equipped with new dose reduction features such as the iterative
model reconstruction technology. Also, the identification of higher
cancer risk age groups and types of CT scans is a useful approach to
patient protection safety. Additionally, this paper provides some sci-
entifically based evidence for complex medical decisions regarding the
use of ionising radiation in young population.
5. Conclusion
The first estimation of the CT scan use in the 0–20 year old Spanish
population indicated that in 2013, 105,802 CT scans were performed,
representing a crude rate of 10.9 scans per 1000 Spanish young people.
The sizeable amount of contemporary clinical data allowed the re-
construction of the doses used and the assertion that they were relatable
to those reported in similar studies in other countries. Using the esti-
mated parameters from the risk models proposed by the BEIR VII report
and Berrington de González it was estimated that 168.6 (30.1–421.1)
additional cancer cases may occur over the life course of this exposed
population, mainly of the thyroid, oral cavity and pharynx, lung and
colon. This represented an attributable risk percent of about 0.43%
(0.08%–1.1%), which provides an important piece of information when
assessing the risk-benefit of a CT scan in a paediatric patient. Although
the minimisation of the radiation exposure of the patient must guide the
clinical practice, the estimated infinitesimal increase in risk may help
easing the concerns regarding well justified CT examinations.
Supplementary data to this article can be found online at https://
doi.org/10.1016/j.envint.2018.07.020.
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